# The Medicines for Human Use (Clinical Trials) Regulations 2004, Paragraph 1


In this Schedule—
“authorisation” means a manufacturing authorisation; and
“time allowed” means the period of 28 days or such extended period as the licensing authority may in any particular case allow.

---
Source: https://www.legislation.gov.uk/uksi/2004/1031/schedule/8/paragraph/1 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-regulations-2004/schedule-8/paragraph-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.